medigraphic.com
ISSN 1561-3054 (Electronic)

2022, Number 2

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (2)

Massive splenomegaly in the course of disseminated histoplasmosis reactivation in an AIDS patient

Martínez FL, Campos GMP, Serrano SCA, Torres CBL, Arteaga HE

Language: Spanish
References: 16
Page:
PDF size: 698.64 Kb.


ABSTRACT

Introduction: Disseminated histoplasmosis is the most frequent form of presentation of this endemic mycosis in AIDS patients. Splenomegaly commonly occurs as a consequence of it, but it is not usually massive.
Objective: To describe an uncommon case of massive splenomegaly caused by disseminated histoplasmosis in an AIDS patient.
Clinical case: The case of an AIDS patient diagnosed 14 years ago is presented. Since diagnosis, the patient has been under antiretroviral treatment irregularly. The first event of this mycosis was 10 years ago. In that occasion, antimitotic treatment was prescribed for four months without secondary prophylaxis. Six months later, symptoms suggestive of reactivation of the disease started. The patient remained symptomatic on a recurrent basis over these years, and attended recently to the hospital in an advanced stage of the disease with large lymphadenopathies and massive hepatosplenomegaly. Diagnostic was confirmed by node biopsy, and antimycotic treatment was indicated, resulting in the resolution of the symptoms and an evident reduction of the enlarged organs.
Conclusions: Massive splenomegaly can be present in this disease. In this case, it should have been originated due to a long reactivation period which was determined by the varying and advanced immunosuppressed state, the irregularity with the antiretroviral treatment, and the lack of secondary prophylaxis for the mycosis.


REFERENCES

  1. Myint T, Leedy N, Villacorta Cari E, Wheat LJ. HIV-Associated Histoplasmosis: Current Perspectives. HIV AIDS (Auckl). 2020 [Acceso 09/01/2021];12:113-25. Disponible en: Disponible en: https://www.dovepress.com/hiv-associated-histoplasmosis-current-perspectives-peer-reviewed-fulltext-article-HIV 1.

  2. O'Reilly RA. Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995, 1913 to 1962: 2,056 patients. West J Med. 1998 [Acceso 09/01/2021];169(2):78-87. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/9735688 2.

  3. O'Reilly RA. Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995, 1963 to 1995: 449 patients. West J Med. 1998 [Acceso 09/01/2021];169(2):88-97 1998 [Acceso 09/01/2021];169(2):88-97 https://pubmed.ncbi.nlm.nih.gov/9735689 3.

  4. Henke O, Mapendo PJ, Mremi A, Mmbaga LG, Pallangyo AE, Harbaum T, et al. Skin maculae, chronic diarrhea, cachexia, and splenomegaly-Late presentation of the first autochthonous case of visceral leishmaniasis in Tanzania. PLoS Negl Trop Dis. 2021 [Acceso 09/01/2021];15(1):e0008925-e. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/33444339 4.

  5. Notopuro PB, Hajat A, Sedana MP. Pancytopenia and Progressive Splenomegaly in Patient with Disseminated Histoplasmosis. Indonesian J Clinical Pathology and Medical Laboratory. 2021 [Acceso 09/01/2021];27(2):228-31. Disponible en: Disponible en: https://indonesianjournalofclinicalpathology.org/index.php/patologi/article/view/1621 5.

  6. Hackett LW. La medición del bazo en la malaria. J Revista Peruana de Medicina Experimental y Salud Pública. 1943 [Acceso 09/01/2021];2(4):305-19. Disponible en: Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46341943000400001&nrm=iso 6.

  7. Akram SM, Koirala J. Histoplasmosis. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright (c) 2021, StatPearls Publishing LLC.; 2021 [Acceso 09/01/2021]. Disponible en: Disponible en: www.nvbi.nlm.nih.gov/books/NBK448185/ 7.

  8. Nahar L, Benzamin M, Sarkar N, Roy U, Nahar K, Rukunuzzaman M, et al. A 8- year Bangladeshi girl with disseminated histoplasmosis, presented as chronic liver disease with portal hypertension: a rare case report. BMC Pediatrics. 2020;20(1):284. DOI: https://doi.org/10.1186/s12887-020-02189-48.

  9. Martin-Iguacel R, Kurtzhals J, Jouvion G, Nielsen SD, Llibre JM. Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review. Infection. 2014;42(4):611-20. DOI: https://doi.org/10.1007/s15010-014-0611-79.

  10. Ramos IC, Soares YC, Damasceno LS, Libório MP, Farias LABG, Heukelbach J, et al. Predictive factors for disseminated histoplasmosis in AIDS patients with fever admitted to a reference hospital in Brazil. Rev Soc Bras Med Trop. 2018 [Acceso 09/01/2021];51(4):479-84. Disponible en: Disponible en: https://www.scielo.br/j/rsbmt/a/LqdkBFXt3J6MwDNC3GHwWVB/?lang=en 10.

  11. Daher EF, Silva Jr GB, Barros FAS, Takeda CFV, Mota RMS, Ferreira MT, et al. Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Tropical Medicine and International Health. 2007 [Acceso 09/01/2021];12(9):1108-15. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-3156.2007.01894.x11.

  12. Darling ST. The Morphology of The Parasite (Histoplasma capsulatum) and The Lesions of Histoplasmosis, A Fatal Disease of Tropical America. Journal of Experimental Medicine. 1909;11(4):515-31. DOI: https://doi.org/10.1084/jem.11.4.51512.

  13. Radin DR. Disseminated histoplasmosis: abdominal CT findings in 16 patients. American Journal of Roentgenology. 1991 [Acceso 09/01/2021];157(80361-803X [Print]):955-8. Disponible en: www.ajronline.org/doi/10.2214/ajr.157.5.192781613.

  14. Khan AM, Shahzad SR, Najjar S, Foulke L. Disseminated Histoplasmosis with Concurrent Hairy Cell Leukemia. Cureus. 2020 [Acceso 09/01/2021];12(1):e6825-e. Disponible en: Disponible en: https://www.cureus.com/articles/26386-disseminated-histoplasmosis-with-concurrent-hairy-cell-leukemia 14.

  15. Ling Q, Zhu W, Lu Q, Jin T, Ding S. Disseminated histoplasmosis in an immunocompetent patient from an endemic area: A case report. Medicine (Baltimore). 2018;97(29):e11486-e. DOI: https://doi.org/10.1097/MD.000000000001148615.

  16. McKinsey DS. Treatment and Prevention of Histoplasmosis in Adults Living with HIV. J Fungi (Basel). 2021 [Acceso 09/01/2021];7(6):429. Disponible en: Disponible en: https://www.mdpi.com/2309-608X/7/6/429/htm 16.




2020     |     www.medigraphic.com